European Primary Care Cardiovascular Society

How are we doing: The gap between guideline LDL-c goals and current practice

Experts in dialogue - LDL-c goal attainment in high risk patients

15' education - May 11, 2021 - Prof. François Mach, MD - Geneva, Switzerland & prof. Erik Stroes, MD, PhD - Amsterdam, The Netherlands

Educational information

The series 'Experts in dialogue - LDL-c goal attainment in high risk patients' has been developed in response to an Expert Meeting, in which the current situation on LDL-c guideline implementation, barriers of implementation and solutions to improve the proportion of patients achieving their target goals were discussed.

Other topics covered in this series

This educational video is part of a series with different expert discussing the issues and challenges on LDL-c goal attainment in high CV risk patients:

- The proven case for LDL-c lowering Prof. Kausik Ray, London, UK and prof. John Kastelein Amsterdam, The Netherlands

- What are current challenges and barriers in achieving LDL-c goals? Prof. Lale Tokgözoğlu, MD. Ankara, Turkey and prof. Kausik Ray, London, UK

- Combination therapy for statin-intolerant patients Prof. Maciej Banach, Lodz, Poland and prof. Ulrich Laufs, Leipzig, Germany


Prof. François Mach, MD is cardiologist at the Geneva University Hospital in Switzerland.

Prof. Erik Stroes, MD, PhD - Professor of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.


The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS.

Funding for the Expert Meeting was provided by unrestricted educational grants received from Amgen and Sanofi. The sponsors did not attend and influence the Expert Meeting and the video recording.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: